Centre for Computational Science, Department of Chemistry, UCL, London, UK.
Biochemistry. 2012 Aug 21;51(33):6487-9. doi: 10.1021/bi300432u. Epub 2012 Aug 8.
The development of resistance to different drugs remains a major problem for a wide range of infections. In particular, combinations of specific mutations, which individually demonstrate no effect, exhibit significant cooperativity. Here we show that changes to the energy of ligand binding in different resistant HIV-1 proteases are correlated with the creation of water binding sites in the active site. This correlation is conserved across two drugs (ritonavir and lopinavir). We propose that individual mutations induce changes in flap packing that are insufficient to allow water binding but in combination allow access, leading to the observed cooperative resistance.
不同药物的耐药性发展仍然是广泛感染的主要问题。特别是,单独没有效果的特定突变组合表现出显著的协同作用。在这里,我们表明不同耐药性 HIV-1 蛋白酶中配体结合能的变化与活性部位中水结合位点的形成相关。这种相关性在两种药物(利托那韦和洛匹那韦)中都得到了保留。我们提出,单个突变诱导瓣包装的变化,这些变化不足以允许水结合,但结合起来允许水进入,导致观察到的协同耐药性。